Sivik Global Healthcare’s Haemonetics HAE Stock Holding History

Sivik Global Healthcare’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-25,000	Closed	-$2.77M	–	55
2021 Q1	$2.77M	Buy	+25,000	New	+$3.09M	1.01%	38
2019 Q1	–	Sell	-5,000	Closed	-$500K	–	62
2018 Q4	$500K	Sell	5,000 -15,000	-75%	-$1.58M	0.27%	46
2018 Q3	$2.29M	Buy	+20,000	New	+$2.07M	0.82%	49
2018 Q2	–	Sell	-26,893	Closed	-$1.97M	–	67
2018 Q1	$1.97M	Buy	+26,893	New	+$1.85M	0.92%	46

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return

LCP

LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return

Sivik Global Healthcare's HAE Position: Q2 2021 in Review

Sivik Global Healthcare sold out of Haemonetics (HAE) in Q2 2021, closing a stake of 25,000 shares — an estimated $2.77M sold.

Sivik Global Healthcare first reported a position in HAE in Q1 2018 and held it in 4 quarters. The position peaked at $2.77M in Q1 2021. 258 funds tracked by Wall St. Rank hold HAE as of Q2 2021.

Sivik Global Healthcare reported no remaining Haemonetics position as of Q2 2021 after selling out during the quarter.
Sivik Global Healthcare sold 25,000 Haemonetics shares in Q2 2021, an estimated $2.77M.
Sivik Global Healthcare first reported a position in Haemonetics in Q1 2018 and held it in 4 quarters.
Sivik Global Healthcare's Haemonetics position peaked at $2.77M in Q1 2021.
258 funds tracked by Wall St. Rank held Haemonetics as of Q2 2021.

Based on Sivik Global Healthcare's 13F filing for Q2 2021, filed 10 Aug 2021.